SCHEMBL18999986

SCHEMBL18999986

Cc1cc(C(C)C)c(C(C)C)c(C(C)C)n1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.30
APOBEC3G Q9HC16 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13438497 0.80 CYP1A2 (0.33) POLBAPOBEC3G
SCHEMBL25467522 0.78 NOS3 (0.36)
SCHEMBL22020969 0.77 GCGR (0.33)
SCHEMBL21625512 0.77 NOS3 (0.35) POLB
SCHEMBL27448149 0.74 MAPT (0.37) POLB
SCHEMBL27326054 0.74 NOS3 (0.35)
SCHEMBL27448146 0.72 KDM5A (0.38)
SCHEMBL21637150 0.70 MAPT (0.35)
SCHEMBL26539121 0.70 NOS3 (0.41)
SCHEMBL19021948 0.68 POLB (0.33) POLBAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174653-A1 TLR7/8 ANTAGONISTS AND USES THEREOF MERCK PATENT GMBH (DE) 2017-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174653-A1 TLR7/8 ANTAGONISTS AND USES THEREOF TLR7, TLR8, TLR9 POLB 1929/4885APOBEC3G 1107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.